Pages

▼
Monday, June 29, 2026

Drug Channels News Roundup, June 2026: PBM Shakeout Accelerates, 340B Enters a New Era, Rebate Questions Persist, Mark Cuban Wins Again, and Ge Bai’s HHS Nomination

›
Happy 250th birthday, America! Before you launch your semiquincentennial festivities, Drug Channels offers some fireworks of our own: The P...
Friday, June 26, 2026

BlinkRx Insights: The Questions Manufacturers Wish They Had Asked Before Selecting a Patient Services Partner

›
Today’s guest post comes from Geoffrey Chaiken and Matthew Chaiken, Co-founders of BlinkRx. Geoffrey and Matthew examine the important role...
Tuesday, June 23, 2026

Pharmacist Salaries and Employment in 2025: Retail Declines, Hospital Gains

›
By Adam J. Fein, Ph.D. and Greis Kapexhiu It’s time for Drug Channels ’ annual look at pharmacist salaries and employment. The latest dat...
Thursday, June 18, 2026

The Digital Front Door to Specialty Therapy May Not Be a Specialty Pharmacy

›
Today’s guest post comes from Nareda Mills, President of Patient Solutions at Inizio Engage. Nareda examines how growing access complexity ...
Wednesday, June 17, 2026

Drug Channels News Roundup, Mid-June 2026: Biosimilar Development Barriers, Hospital Specialty Pharmacy Growth, Medicaid Incentives, Drug Pricing Tradeoffs, and the Prescription-Filling Process

›
By Bryce Platt, PharmD Summer officially starts this weekend! Consider doing a few of your lifting sets (or work meetings) outside. The ...
Tuesday, June 16, 2026

The IRA Fixed One Medicare Part D Distortion—But Patients Now Face New Tradeoffs

›
By Bryce Platt, PharmD For years, Medicare Part D plans often preferred high-list/high-rebate branded multiple sclerosis (MS) drugs over l...
Friday, June 12, 2026

Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated Care (rerun)

›
This week, we’re rerunning some popular posts while we prepare for today’s live video webinar: 340B in 2026: Market Shifts, Policy Battles, ...
Thursday, June 11, 2026

The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground (rerun)

›
This week, we’re rerunning some popular posts while we prepare for tomorrow’s live video webinar: 340B in 2026: Market Shifts, Policy Battle...
Wednesday, June 10, 2026

Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update (rerun)

›
This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles,...
Tuesday, June 09, 2026

The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments (rerun)

›
This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles,...
Monday, June 08, 2026

The Top 15 U.S. Pharmacies of 2025: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)

›
This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles,...
Friday, June 05, 2026

Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight

›
Today’s guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx’s proprietary data an...